TPG Capital Asia completes acquisition of Gribbles Pathology

KUALA LUMPUR: TPG Capital Asia has completed its acquisition of Gribbles Pathology (M) Sdn Bhd, a leading pathology lab in Malaysia.

According to TPG Capital, the Asian investment platform of global alternative asset firm TPG, the acquisition forms part of its A$279 million (RM831.9mil) purchase of Healthscope Ltd's Asian pathology laboratories in Malaysia, Singapore, and Vietnam.

"I'm delighted to work with TPG on another healthcare investment in Malaysia,” said incoming chairman of Gribbles Tan Sri Dr Yahya Awang (pic).

“Gribbles Pathology has been a trusted partner to many independent clinics and hospitals in the country. We hope to be able to continue to grow our presence in Malaysia and at the same time be a leader in the application of new technology and quality of service to the doctors and healthcare professionals that depend on us.”